Article Details
Retrieved on: 2024-05-30 16:58:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MRNA. -0.09%. (Reuters) -The U.S. government is nearing an agreement to fund a late-stage trial of Moderna (NASDAQ:MRNA)'s mRNA bird flu vaccine ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here